Covered recipient · General Payments record
SUSANNA LEE MAHER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021
$266.54
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $266.54 | 15 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $81.55 | 5 |
| Daiichi Sankyo Inc. | $42.37 | 2 |
| Astellas Pharma US Inc | $42.31 | 2 |
| Hologic Sales and Service, LLC | $39.39 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.06 | 1 |
| Amgen Inc. | $16.82 | 1 |
| Mylan Pharmaceuticals Inc. | $13.21 | 1 |
| Exeltis, USA Inc. | $12.83 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $266.54 | 15 |
Payment records · PY2021 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $18.75 | 01/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794829201 | CMS |
| AbbVie Inc. | $15.99 | 02/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794829205 | CMS |
| AbbVie Inc. | $18.05 | 03/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794829209 | CMS |
| AbbVie Inc. | $16.64 | 03/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794829213 | CMS |
| AbbVie Inc. | $12.12 | 04/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794829215 | CMS |
| Amgen Inc. | $16.82 | 02/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826251579 | CMS |
| Astellas Pharma US Inc | $19.95 | 03/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821725619 | CMS |
| Astellas Pharma US Inc | $22.36 | 04/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821725625 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $18.06 | 04/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 789046575 | CMS |
| Daiichi Sankyo Inc. | $20.73 | 01/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836248107 | CMS |
| Daiichi Sankyo Inc. | $21.64 | 05/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836291161 | CMS |
| Exeltis, USA Inc. | $12.83 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806201191 | CMS |
| Hologic, LLC | $18.46 | 08/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 783391177 | CMS |
| Hologic, LLC | $20.93 | 09/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 783391179 | CMS |
| Mylan Pharmaceuticals Inc. | $13.21 | 03/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 965459991 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.